Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Illumina Buying Verinata in Up to $450M Deal

By Pharmaceutical Processing | January 7, 2013

SAN DIEGO (AP) — Genetic analysis instrument company Illumina is buying prenatal testing company Verinata Health Inc. in a deal worth up to $450 million.

Illumina Inc. said Monday that it will pay $350 million for privately-held Verinata and may pay up to an additional $100 million through 2015 if certain targets are met. The transaction will be financed mostly with available cash.

Ilumina’s shares fell $5.24, or 9.6 percent, to $49.52 in premarket trading. Its shares peaked for the past year at $57 on Dec. 20. They fell as low as $28.72 almost a year ago.

Verinata’s verifi test analyzes cell-free fetal DNA naturally found in a pregnant woman’s blood to look for missing or extra copies of chromosomes. The test can detect Down syndrome, Edwards syndrome and Patau syndrome. The test also includes the option to evaluate sex chromosome abnormalities, such as Turner syndrome, Triple X, Klinefelter syndrome and Jacobs syndrome.

Illumina, based in San Diego, expects the acquisition to reduce its 2013 adjusted earnings by about 20 cents per share and then add to its earnings starting in 2014 and beyond. Verinata is based in San Carlos, Calif.

 

 

Related Articles Read More >

This is the logo of Hikma.
Hikma to spend another $1B on US manufacturing, R&D
Sandoz Logo 2025
Sandoz breaks ground on biosimilar plant in Slovenia
Nymi Logo_2022 (1)
Nymi, Caliber partner on passwordless authentication for pharma manufacturing
Building a resilient pharma supply chain
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE